These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8732374)

  • 21. Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence from Grampian region early anistreplase trial (GREAT).
    Rawles J
    BMJ; 1996 Jan; 312(7025):212-5. PubMed ID: 8563585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiographic evidence of reperfusion occurring before hospital admission. A Grampian Region Early Anistreplase Trial (GREAT) sub-study.
    Trent R; Adams J; Rawles J
    Eur Heart J; 1994 Jul; 15(7):895-7. PubMed ID: 7925509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of survival using anistreplase (Eminase)].
    Murray RG
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():37-40. PubMed ID: 2108645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects on infarct size and left ventricular function of early intravenous injection of anistreplase in acute myocardial infarction. The APSIM Study Investigators.
    Bassand JP; Bernard Y; Lusson JR; Machecourt J; Cassagnes J; Borel E
    Clin Cardiol; 1990 Mar; Suppl 5():V39-44; discussion V67-72. PubMed ID: 2182240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety of anistreplase from the placebo-controlled AIMS study (anistreplase Intervention Mortality Study). The AIMS Study Group.
    Fox KA
    Clin Cardiol; 1990 Mar; Suppl 5():V22-6; discussion V27-32. PubMed ID: 2182237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial salvage with early anistreplase treatment.
    Rawles JM
    Clin Cardiol; 1997 Nov; 20(11 Suppl 3):III6-10. PubMed ID: 9422856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary reperfusion rates in acute myocardial infarction patients after thrombolytic treatment with anistreplase: correlation with the delay from onset of symptoms to treatment: a review of 424 case records of patients admitted to coronary reperfusion studies with anistreplase.
    Leizorovicz A; Boissel JP; Robert F
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):34-9. PubMed ID: 1375685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of mortality from acute myocardial infarction in patients receiving anistreplase with those not receiving thrombolysis.
    Ozbek C; Heisel A; Krause M; Berg G; Hammer B; Bay W; Sen S; Schieffer H
    Am J Cardiol; 1995 Dec; 76(16):1103-7. PubMed ID: 7484891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prehospital thrombolysis in rural emergency room and subsequent transport to a coronary care unit: Ravenna Myocardial Infarction (RaMI) trial.
    Coccolini S; Berti G; Bosi S; Pretolani M; Tumiotto G
    Int J Cardiol; 1995 Aug; 49 Suppl():S47-58. PubMed ID: 7591317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability of thrombolytic coronary reperfusion: an angiographic study of streptokinase and anistreplase.
    Sorensen SG; Hackworthy RA; Fitzpatrick PG; Menlove R; Anderson JL
    Clin Cardiol; 1990 Mar; Suppl 5():V15-9; discussion V27-32. PubMed ID: 2182235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ST-segment analysis: a useful marker for reperfusion after thrombolysis with APSAC? The Belgian EMS Study Group.
    Bossaert L; Conraads V; Pintens H
    Eur Heart J; 1991 Mar; 12(3):357-62. PubMed ID: 2040318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals.
    Eur Heart J; 2000 Sep; 21(18):1537-46. PubMed ID: 10973768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
    Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M
    Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT).
    Rawles J
    J Am Coll Cardiol; 1994 Jan; 23(1):1-5. PubMed ID: 8277066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis.
    Solomon SD; Ridker PM; Antman EM
    Circulation; 1993 Dec; 88(6):2575-81. PubMed ID: 8252668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anistreplase: a new thrombolytic for the treatment of acute myocardial infarction.
    Munger MA; Forrence EA
    Clin Pharm; 1990 Jul; 9(7):530-40. PubMed ID: 2198125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The magnitude of the benefit from preCCU thrombolysis in acute myocardial infarction: a long term follow up.
    Coccolini S; Berti G; Maresta A
    Int J Cardiol; 1998 May; 65 Suppl 1():S49-56. PubMed ID: 9706827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.